InsiderFlow

ETON

Eton Pharmaceuticals, Inc.$64.03+0.10 (+0.16%)
Prev Close$63.93·MCap$1.97B·P/E—·Vol409.7K·Yield—
▲

Buys (12M)

0

$0.00

▼

Sells (12M)

19

$31.56M

◆

Net Activity

Net Seller

$31.56M

●

Active Insiders

9

last 12 mo

Over the past 12 months, insider activity at Eton Pharmaceuticals, Inc. (ETON) has been exclusively selling, with 0 insider purchases totaling $0.00 and 19 insider sales totaling $31.56M. The most recent insider transaction was by Erdogan-Trinkaus Ipek (officer: Chief Commercial Officer), who sold $235.9K worth of shares on Nov 12, 2026. Eton Pharmaceuticals, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $1.97B.

ETON Insider Trading Activity

DateInsiderTypeValue
Nov 12, 2026 Erdogan-Trinkaus IpekSell$235.9K
Nov 10, 2026 CASAMENTO CHARLES JSell$5.35M
Oct 6, 2026 Krempa DavidSell$229.4K
Aug 28, 2026 MAIER PAUL VSell$2.95M
Aug 24, 2026 Krempa DavidSell$1.63M
Aug 20, 2026 BRYNJELSEN SEANSell$6.09M
Jul 16, 2026 Opaleye Management Inc.Sell$1.06M
Jul 7, 2026 Opaleye Management Inc.Sell$4.77M
Jun 17, 2026 Adams Jennifer McKieSell$1.62M
May 29, 2026 BRYNJELSEN SEANSell$3.83M
May 27, 2026 Krempa DavidSell$3.23M
Feb 3, 2026 RIEDEL NORBERT GSell$132.6K
Jan 12, 2026 BRYNJELSEN SEANSell$77.2K
Jan 12, 2026 Gruber James R.Sell$35.5K
Jan 12, 2026 Krempa DavidSell$30.3K
Dec 12, 2025 BRYNJELSEN SEANSell$113.3K
Dec 11, 2025 Erdogan-Trinkaus IpekSell$1.4K
Dec 11, 2025 Gruber James R.Sell$77.2K
Dec 11, 2025 Krempa DavidSell$106.5K
Aug 19, 2025 Gruber James R.Sell$673.7K
Jun 12, 2025 Krempa DavidSell$504.3K
Jun 3, 2025 BRYNJELSEN SEANSell$3.59M0.8% OS
Sep 22, 2022 BRYNJELSEN SEANBuy$21.0K
Aug 20, 2021 BRYNJELSEN SEANBuy$43.2K
Aug 20, 2021 Troutman William WilsonBuy$22.1K
Jun 3, 2021 BRYNJELSEN SEANBuy$29.8K

ETON Insider Buying Activity

The following table shows recent insider purchases of Eton Pharmaceuticals, Inc. (ETON) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Sep 22, 2022 BRYNJELSEN SEANBuy$21.0K
Aug 20, 2021 BRYNJELSEN SEANBuy$43.2K
Aug 20, 2021 Troutman William WilsonBuy$22.1K
Jun 3, 2021 BRYNJELSEN SEANBuy$29.8K

ETON Insider Selling Activity

The following table shows recent insider sales of Eton Pharmaceuticals, Inc. (ETON) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Nov 12, 2026 Erdogan-Trinkaus IpekSell$235.9K
Nov 10, 2026 CASAMENTO CHARLES JSell$5.35M
Oct 6, 2026 Krempa DavidSell$229.4K
Aug 28, 2026 MAIER PAUL VSell$2.95M
Aug 24, 2026 Krempa DavidSell$1.63M
Aug 20, 2026 BRYNJELSEN SEANSell$6.09M
Jul 16, 2026 Opaleye Management Inc.Sell$1.06M
Jul 7, 2026 Opaleye Management Inc.Sell$4.77M
Jun 17, 2026 Adams Jennifer McKieSell$1.62M
May 29, 2026 BRYNJELSEN SEANSell$3.83M
May 27, 2026 Krempa DavidSell$3.23M
Feb 3, 2026 RIEDEL NORBERT GSell$132.6K
Jan 12, 2026 BRYNJELSEN SEANSell$77.2K
Jan 12, 2026 Gruber James R.Sell$35.5K
Jan 12, 2026 Krempa DavidSell$30.3K
Dec 12, 2025 BRYNJELSEN SEANSell$113.3K
Dec 11, 2025 Erdogan-Trinkaus IpekSell$1.4K
Dec 11, 2025 Gruber James R.Sell$77.2K
Dec 11, 2025 Krempa DavidSell$106.5K
Aug 19, 2025 Gruber James R.Sell$673.7K
Jun 12, 2025 Krempa DavidSell$504.3K
Jun 3, 2025 BRYNJELSEN SEANSell$3.59M0.8% OS

ETON Insiders

Erdogan-Trinkaus Ipek

officer: Chief Commercial Officer

Sold $237.4K
2 tradesLast: Nov 12, 2026
CASAMENTO CHARLES J

director

Sold $5.35M
1 tradesLast: Nov 10, 2026
Krempa David

officer: Chief Business Officer

Sold $5.73M
6 tradesLast: Oct 6, 2026
MAIER PAUL V

director

Sold $2.95M
1 tradesLast: Aug 28, 2026
BRYNJELSEN SEAN

President & CEO

Bought $94.0KSold $13.70M
8 tradesLast: Aug 20, 2026
Opaleye Management Inc.

10 percent owner

Sold $5.83M
2 tradesLast: Jul 16, 2026
Adams Jennifer McKie

director

Sold $1.62M
1 tradesLast: Jun 17, 2026
RIEDEL NORBERT G

Director

Sold $132.6K
1 tradesLast: Feb 3, 2026
Gruber James R.

Chief Financial Officer

Sold $786.4K
3 tradesLast: Jan 12, 2026
Troutman William Wilson

CFO, Treasurer & Secretary

Bought $22.1K
1 tradesLast: Aug 20, 2021